Assessing the Potential of HPV16 E6 Seroprevalence as a Biomarker for Anal Dysplasia and Cancer Screening-A Systematic Review and Meta-Analysis
In conclusion, while HPV16 E6 seroprevalence demonstrates specificity as a potential biomarker for HPV-related AC, its utility as a standalone screening tool may be limited. Instead, it could serve effectively as a confirmation test, particularly in high-risk populations, alongside other diagnostic methods. Further research is imperative to explore HPV16 E6 seroconversion dynamics and alternative screening algorithms.PMID:38542409 | DOI:10.3390/ijms25063437
Source: Anal Sci - Category: Chemistry Authors: Sara Tous Mariona Guillamet Tim Waterboer Laia Alemany Sonia Paytubi Source Type: research
More News: Anal Cancer | Anoscopy | Cancer | Cancer & Oncology | Cervical Cancer | Chemistry | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Oropharyngeal Cancer | Study